chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Product dose omission issue
Clinical narrative: After 1st dose had bronchitis, is better now but the symptoms of bronchitis lingered; Patient did not get the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (After 1st dose had bronchitis, is better now but the symptoms of bronchitis lingered) and PRODUCT DOSE OMISSION ISSUE (Patient did not get the 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BRONCHITIS (After 1st dose had bronchitis, is better now but the symptoms of bronchitis lingered) and PRODUCT DOSE OMISSION ISSUE (Patient did not get the 2nd dose). At the time of the report, BRONCHITIS (After 1st dose had bronchitis, is better now but the symptoms of bronchitis lingered) and PRODUCT DOSE OMISSION ISSUE (Patient did not get the 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter  Treatment information was not provided   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Body temperature fluctuation, Fatigue, Headache
Clinical narrative: body temperature changes; Headaches; Tiredness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE FLUCTUATION (body temperature changes), HEADACHE (Headaches) and FATIGUE (Tiredness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BODY TEMPERATURE FLUCTUATION (body temperature changes), HEADACHE (Headaches) and FATIGUE (Tiredness). At the time of the report, BODY TEMPERATURE FLUCTUATION (body temperature changes), HEADACHE (Headaches) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.
Sex: U
Vaccine: COVID19
Symptoms: Dengue fever
Clinical narrative: Dengue; This spontaneous case was reported by a physician and describes the occurrence of DENGUE FEVER (Dengue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DENGUE FEVER (Dengue). At the time of the report, DENGUE FEVER (Dengue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 1st dose 20Apr201, no 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose 20Apr201, no 2nd dose yet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose 20Apr201, no 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (1st dose 20Apr201, no 2nd dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products was provided by the reporter. No treatment information was provided by the reporter.   Reporter did not allow further contact
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (headache) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 035B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (headache) outcome was unknown.            No concomitant products was provided by the reporter. No treatment information was provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Extra dose administered, Headache, Nasopharyngitis
Clinical narrative: Difficulty breathing; Cold; Headache; Chills; Extra dose; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNEA (Difficulty breathing), NASOPHARYNGITIS (Cold), HEADACHE (Headache), CHILLS (Chills) and EXTRA DOSE ADMINISTERED (Extra dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung cancer and Vocal cord disorder NOS in 2013. Concurrent medical conditions included Arthritis since 2013, Allergy, Nausea and COPD. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for COPD, PREDNISONE for Dyspnea, ONDANSETRON (ZOFRAN [ONDANSETRON]) for Nausea, OXYGEN, GUAIFENESIN (MUCINEX), MONTELUKAST SODIUM (SINGULAIR), APIXABAN (ELIQUIS), ACETYLSALICYLIC ACID (BAYER ASPIRIN), PARACETAMOL (TYLENOL ARTHRITIS), ERGOCALCIFEROL (VITAMIN D2), OXYCODONE and ALPRAZOLAM (XANAX) for an unknown indication.    On 18-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced DYSPNEA (Difficulty breathing), NASOPHARYNGITIS (Cold) and CHILLS (Chills). 18-Aug-2021, the patient experienced HEADACHE (Headache) and EXTRA DOSE ADMINISTERED (Extra dose). On 18-Aug-2021, EXTRA DOSE ADMINISTERED (Extra dose) had resolved. At the time of the report, DYSPNEA (Difficulty breathing), NASOPHARYNGITIS (Cold), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment history was not reported. Patient took the Fentanyl with saline and Advair 500/50 for COPD. Antibiotics once daily to help clear the lungs and prevent from pneumonia   This case was linked to MOD-2021-294195 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Fever; Arm had a rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Arm had a rash) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Immunocompromised (compromised immune system with leukemia). Concurrent medical conditions included Leukemia.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Arm had a rash) and PYREXIA (Fever). At the time of the report, RASH (Arm had a rash) and PYREXIA (Fever) had resolved.            No concomitant products was provided by the reporter.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-294291 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Report side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Report side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report side effect). At the time of the report, VACCINATION COMPLICATION (Report side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products was provided by the reporter. No treatment information was provided by the reporter.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary mass, Bone pain, Cough, Fatigue
Clinical narrative: Joints in their left hand are swollen, red, and painful; bones hurt; a lot of pain in both legs; left underarm a lump; a lump on inner left thigh; cough that doesn't go away; joints in their left hand are swollen, red, and painful; felt exhausted; crawling sensation in their legs; itch; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (crawling sensation in their legs), PRURITUS (itch), JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt) and PAIN IN EXTREMITY (a lot of pain in both legs) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026021A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included ONE A DAY WOMEN'S.    On 15-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Aug-2021, the patient experienced FORMICATION (crawling sensation in their legs) and PRURITUS (itch). On an unknown date, the patient experienced JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt), PAIN IN EXTREMITY (a lot of pain in both legs), AXILLARY MASS (left underarm a lump), LIMB MASS (a lump on inner left thigh), COUGH (cough that doesn't go away), ARTHRALGIA (joints in their left hand are swollen, red, and painful) and FATIGUE (felt exhausted). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 16-Aug-2021, FORMICATION (crawling sensation in their legs) and PRURITUS (itch) had resolved. At the time of the report, JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt), PAIN IN EXTREMITY (a lot of pain in both legs), AXILLARY MASS (left underarm a lump), LIMB MASS (a lump on inner left thigh), COUGH (cough that doesn't go away), ARTHRALGIA (joints in their left hand are swollen, red, and painful) and FATIGUE (felt exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient is taking is a women's one-a-day multivitamin as concomitant drug
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Formication, Joint swelling, Limb mass, Pain in extremity, Pruritus
Clinical narrative: Joints in their left hand are swollen, red, and painful; bones hurt; a lot of pain in both legs; left underarm a lump; a lump on inner left thigh; cough that doesn't go away; joints in their left hand are swollen, red, and painful; felt exhausted; crawling sensation in their legs; itch; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (crawling sensation in their legs), PRURITUS (itch), JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt) and PAIN IN EXTREMITY (a lot of pain in both legs) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026021A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included ONE A DAY WOMEN'S.    On 15-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Aug-2021, the patient experienced FORMICATION (crawling sensation in their legs) and PRURITUS (itch). On an unknown date, the patient experienced JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt), PAIN IN EXTREMITY (a lot of pain in both legs), AXILLARY MASS (left underarm a lump), LIMB MASS (a lump on inner left thigh), COUGH (cough that doesn't go away), ARTHRALGIA (joints in their left hand are swollen, red, and painful) and FATIGUE (felt exhausted). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 16-Aug-2021, FORMICATION (crawling sensation in their legs) and PRURITUS (itch) had resolved. At the time of the report, JOINT SWELLING (Joints in their left hand are swollen, red, and painful), BONE PAIN (bones hurt), PAIN IN EXTREMITY (a lot of pain in both legs), AXILLARY MASS (left underarm a lump), LIMB MASS (a lump on inner left thigh), COUGH (cough that doesn't go away), ARTHRALGIA (joints in their left hand are swollen, red, and painful) and FATIGUE (felt exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient is taking is a women's one-a-day multivitamin as concomitant drug
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Injection site reaction, Paraesthesia, Pruritus
Clinical narrative: injection site reaction; she can feel her skin tingling on both arms; she can feel her skin burning on both arms; skin peel off her face/skin peel off her neck; skin on her face itches; The rectangle traveled over to a scar on her left arm from when she had skin melanoma removed in 2020/skin is red on her face and neck.; moderate fever; sore left arm; chills; The site reaction stayed and turned into a red rectangle.; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (injection site reaction), PARAESTHESIA (she can feel her skin tingling on both arms), SKIN BURNING SENSATION (she can feel her skin burning on both arms), SKIN EXFOLIATION (skin peel off her face/skin peel off her neck) and PRURITUS (skin on her face itches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Skin melanoma (skin melanoma removed in 2020) in 2020 and Laser therapy (laser peel done at a skin care clinic).    On 09-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced INJECTION SITE REACTION (injection site reaction), PARAESTHESIA (she can feel her skin tingling on both arms), SKIN BURNING SENSATION (she can feel her skin burning on both arms), SKIN EXFOLIATION (skin peel off her face/skin peel off her neck), PRURITUS (skin on her face itches), ERYTHEMA (The rectangle traveled over to a scar on her left arm from when she had skin melanoma removed in 2020/skin is red on her face and neck.), PYREXIA (moderate fever), VACCINATION SITE PAIN (sore left arm), CHILLS (chills) and VACCINATION SITE ERYTHEMA (The site reaction stayed and turned into a red rectangle.). At the time of the report, INJECTION SITE REACTION (injection site reaction), PARAESTHESIA (she can feel her skin tingling on both arms), SKIN BURNING SENSATION (she can feel her skin burning on both arms), SKIN EXFOLIATION (skin peel off her face/skin peel off her neck), PRURITUS (skin on her face itches), ERYTHEMA (The rectangle traveled over to a scar on her left arm from when she had skin melanoma removed in 2020/skin is red on her face and neck.), PYREXIA (moderate fever), VACCINATION SITE PAIN (sore left arm), CHILLS (chills) and VACCINATION SITE ERYTHEMA (The site reaction stayed and turned into a red rectangle.) outcome was unknown.            No concomitant products was provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2021-294376 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Skin burning sensation, Skin exfoliation, Vaccination site erythema, Vaccination site pain
Clinical narrative: injection site reaction; she can feel her skin tingling on both arms; she can feel her skin burning on both arms; skin peel off her face/skin peel off her neck; skin on her face itches; The rectangle traveled over to a scar on her left arm from when she had skin melanoma removed in 2020/skin is red on her face and neck.; moderate fever; sore left arm; chills; The site reaction stayed and turned into a red rectangle.; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (injection site reaction), PARAESTHESIA (she can feel her skin tingling on both arms), SKIN BURNING SENSATION (she can feel her skin burning on both arms), SKIN EXFOLIATION (skin peel off her face/skin peel off her neck) and PRURITUS (skin on her face itches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Skin melanoma (skin melanoma removed in 2020) in 2020 and Laser therapy (laser peel done at a skin care clinic).    On 09-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced INJECTION SITE REACTION (injection site reaction), PARAESTHESIA (she can feel her skin tingling on both arms), SKIN BURNING SENSATION (she can feel her skin burning on both arms), SKIN EXFOLIATION (skin peel off her face/skin peel off her neck), PRURITUS (skin on her face itches), ERYTHEMA (The rectangle traveled over to a scar on her left arm from when she had skin melanoma removed in 2020/skin is red on her face and neck.), PYREXIA (moderate fever), VACCINATION SITE PAIN (sore left arm), CHILLS (chills) and VACCINATION SITE ERYTHEMA (The site reaction stayed and turned into a red rectangle.). At the time of the report, INJECTION SITE REACTION (injection site reaction), PARAESTHESIA (she can feel her skin tingling on both arms), SKIN BURNING SENSATION (she can feel her skin burning on both arms), SKIN EXFOLIATION (skin peel off her face/skin peel off her neck), PRURITUS (skin on her face itches), ERYTHEMA (The rectangle traveled over to a scar on her left arm from when she had skin melanoma removed in 2020/skin is red on her face and neck.), PYREXIA (moderate fever), VACCINATION SITE PAIN (sore left arm), CHILLS (chills) and VACCINATION SITE ERYTHEMA (The site reaction stayed and turned into a red rectangle.) outcome was unknown.            No concomitant products was provided by the reporter. No treatment information was provided by the reporter.   This case was linked to MOD-2021-294376 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, Vaccination site pain
Clinical narrative: Moderna Covid-19  vaccination doses were 100mcg; left injection site arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Moderna Covid-19  vaccination doses were 100mcg) and VACCINATION SITE PAIN (left injection site arm is sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 100 microgram. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Moderna Covid-19  vaccination doses were 100mcg) and VACCINATION SITE PAIN (left injection site arm is sore). At the time of the report, ACCIDENTAL UNDERDOSE (Moderna Covid-19  vaccination doses were 100mcg) had resolved and VACCINATION SITE PAIN (left injection site arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant product information was provided. No Treatment Medication was provided. Patient's initial Moderna Covid-19 vaccination doses were 100mcg.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Has not received her second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received her second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received her second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received her second dose) outcome was unknown.            No concomitant medication were provided by the reporter No treatment medication were provided by the reporter   Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Cellulitis, Diarrhoea, Headache, Nausea, Oral herpes
Clinical narrative: herpes sore on my lip; Vaccination site erythema; Vaccination site swelling; Vaccination site pruritus; Vaccination site warmth; Cellulitis of arm; diarrhea; Vaccination site reaction; Headache; Nausea; Fever; Vaccine administered at inappropriate site; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (Cellulitis of arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced DIARRHOEA (diarrhea), VACCINATION SITE REACTION (Vaccination site reaction), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site). On 20-Aug-2021, the patient experienced CELLULITIS (Cellulitis of arm) (seriousness criterion medically significant), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE WARMTH (Vaccination site warmth). On 23-Aug-2021, the patient experienced ORAL HERPES (herpes sore on my lip). At the time of the report, CELLULITIS (Cellulitis of arm), ORAL HERPES (herpes sore on my lip), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE WARMTH (Vaccination site warmth), DIARRHOEA (diarrhea), VACCINATION SITE REACTION (Vaccination site reaction), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site) outcome was unknown.            No concomitant medication was reported. Treatment information was not provided by reporter.   This case was linked to MOD-2021-265574 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered at inappropriate site, Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: herpes sore on my lip; Vaccination site erythema; Vaccination site swelling; Vaccination site pruritus; Vaccination site warmth; Cellulitis of arm; diarrhea; Vaccination site reaction; Headache; Nausea; Fever; Vaccine administered at inappropriate site; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (Cellulitis of arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced DIARRHOEA (diarrhea), VACCINATION SITE REACTION (Vaccination site reaction), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site). On 20-Aug-2021, the patient experienced CELLULITIS (Cellulitis of arm) (seriousness criterion medically significant), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE WARMTH (Vaccination site warmth). On 23-Aug-2021, the patient experienced ORAL HERPES (herpes sore on my lip). At the time of the report, CELLULITIS (Cellulitis of arm), ORAL HERPES (herpes sore on my lip), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE WARMTH (Vaccination site warmth), DIARRHOEA (diarrhea), VACCINATION SITE REACTION (Vaccination site reaction), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site) outcome was unknown.            No concomitant medication was reported. Treatment information was not provided by reporter.   This case was linked to MOD-2021-265574 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: herpes sore on my lip; Vaccination site erythema; Vaccination site swelling; Vaccination site pruritus; Vaccination site warmth; Cellulitis of arm; diarrhea; Vaccination site reaction; Headache; Nausea; Fever; Vaccine administered at inappropriate site; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (Cellulitis of arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced DIARRHOEA (diarrhea), VACCINATION SITE REACTION (Vaccination site reaction), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site). On 20-Aug-2021, the patient experienced CELLULITIS (Cellulitis of arm) (seriousness criterion medically significant), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE WARMTH (Vaccination site warmth). On 23-Aug-2021, the patient experienced ORAL HERPES (herpes sore on my lip). At the time of the report, CELLULITIS (Cellulitis of arm), ORAL HERPES (herpes sore on my lip), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE WARMTH (Vaccination site warmth), DIARRHOEA (diarrhea), VACCINATION SITE REACTION (Vaccination site reaction), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Vaccine administered at inappropriate site) outcome was unknown.            No concomitant medication was reported. Treatment information was not provided by reporter.   This case was linked to MOD-2021-265574 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dyschezia, Dysuria, Gait inability
Clinical narrative: Could not walk; Could not move legs; Could not urinated on herself; Could not defecated on herself; Joint pain; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself), DYSCHEZIA (Could not defecated on herself) and ARTHRALGIA (Joint pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure abnormal.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself) and DYSCHEZIA (Could not defecated on herself). On an unknown date, the patient experienced ARTHRALGIA (Joint pain), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Joint pain, Chills and Headache, at an unspecified dose and frequency. On 29-Jul-2021, GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself) and DYSCHEZIA (Could not defecated on herself) had resolved. At the time of the report, ARTHRALGIA (Joint pain), CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include Blood pressure medication and Diabetes medication.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mobility decreased
Clinical narrative: Could not walk; Could not move legs; Could not urinated on herself; Could not defecated on herself; Joint pain; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself), DYSCHEZIA (Could not defecated on herself) and ARTHRALGIA (Joint pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure abnormal.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself) and DYSCHEZIA (Could not defecated on herself). On an unknown date, the patient experienced ARTHRALGIA (Joint pain), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Joint pain, Chills and Headache, at an unspecified dose and frequency. On 29-Jul-2021, GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself) and DYSCHEZIA (Could not defecated on herself) had resolved. At the time of the report, ARTHRALGIA (Joint pain), CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include Blood pressure medication and Diabetes medication.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19). At the time of the report, COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant and treatment medication was reported by patient.  Patient reported that she was scheduled to receive the 2 dose on 20-Aug-2021 but her doctor told her to wait 90 days after her symptoms gone. Patient have not received 2 dose yet.   This case was linked to MOD-2021-294324 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Myalgia, Pain, Pain in extremity
Clinical narrative: Calves hurt; Tremendous pain; Diarrhea; All the muscles in his body hurt; Chills; Lowgrade fever; Puking; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Calves), PAIN, DIARRHOEA, MYALGIA, and CHILLS in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 08 (or a 9)1D21A (or a 9) and 024C21N) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal and Blood cholesterol abnormal. Concomitant products included PRAVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure abnormal, TEMAZEPAM for an unknown indication.   On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Calves), PAIN, DIARRHOEA, MYALGIA, CHILLS, PYREXIA, and VOMITING. At the time of the report, PAIN IN EXTREMITY (Calves), PAIN, DIARRHOEA, MYALGIA, CHILLS, PYREXIA, and VOMITING had not resolved.            Concomitant medication included pain medication. No treatment medication was provided.   This case was linked to MOD-2021-294487 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Calves hurt; Tremendous pain; Diarrhea; All the muscles in his body hurt; Chills; Lowgrade fever; Puking; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Calves), PAIN, DIARRHOEA, MYALGIA, and CHILLS in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 08 (or a 9)1D21A (or a 9) and 024C21N) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal and Blood cholesterol abnormal. Concomitant products included PRAVASTATIN for Blood cholesterol abnormal, LISINOPRIL for Blood pressure abnormal, TEMAZEPAM for an unknown indication.   On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Calves), PAIN, DIARRHOEA, MYALGIA, CHILLS, PYREXIA, and VOMITING. At the time of the report, PAIN IN EXTREMITY (Calves), PAIN, DIARRHOEA, MYALGIA, CHILLS, PYREXIA, and VOMITING had not resolved.            Concomitant medication included pain medication. No treatment medication was provided.   This case was linked to MOD-2021-294487 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Got COVID after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got COVID after vaccination). At the time of the report, COVID-19 (Got COVID after vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not provided. Treatment information was not provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Illness, Lung disorder, Myalgia
Clinical narrative: weird, itchy, rash all over her body; weird, itchy, rash all over her body; severe soreness with my arm; tiredness; very sick; caught covid; Lung issue; viral rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (weird, itchy, rash all over her body), ILLNESS (very sick), COVID-19 (caught covid), LUNG DISORDER (Lung issue) and VIRAL RASH (viral rash) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced ILLNESS (very sick), COVID-19 (caught covid), LUNG DISORDER (Lung issue), VIRAL RASH (viral rash), MYALGIA (severe soreness with my arm) and FATIGUE (tiredness). In July 2021, the patient experienced RASH PRURITIC (weird, itchy, rash all over her body) and RASH (weird, itchy, rash all over her body). The patient was treated with PREDNISONE ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and TRIAMCINOLONE (topical) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (weird, itchy, rash all over her body), ILLNESS (very sick), COVID-19 (caught covid), LUNG DISORDER (Lung issue), VIRAL RASH (viral rash), RASH (weird, itchy, rash all over her body), MYALGIA (severe soreness with my arm) and FATIGUE (tiredness) outcome was unknown.            No Concomitant medications were provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Viral rash
Clinical narrative: weird, itchy, rash all over her body; weird, itchy, rash all over her body; severe soreness with my arm; tiredness; very sick; caught covid; Lung issue; viral rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (weird, itchy, rash all over her body), ILLNESS (very sick), COVID-19 (caught covid), LUNG DISORDER (Lung issue) and VIRAL RASH (viral rash) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced ILLNESS (very sick), COVID-19 (caught covid), LUNG DISORDER (Lung issue), VIRAL RASH (viral rash), MYALGIA (severe soreness with my arm) and FATIGUE (tiredness). In July 2021, the patient experienced RASH PRURITIC (weird, itchy, rash all over her body) and RASH (weird, itchy, rash all over her body). The patient was treated with PREDNISONE ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and TRIAMCINOLONE (topical) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (weird, itchy, rash all over her body), ILLNESS (very sick), COVID-19 (caught covid), LUNG DISORDER (Lung issue), VIRAL RASH (viral rash), RASH (weird, itchy, rash all over her body), MYALGIA (severe soreness with my arm) and FATIGUE (tiredness) outcome was unknown.            No Concomitant medications were provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling
Clinical narrative: swelling of both wrists; pain in my finger joints; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swelling of both wrists) and ARTHRALGIA (pain in my finger joints) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Polymyalgia rheumatica (treated with prednisone in the past.).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (swelling of both wrists) and ARTHRALGIA (pain in my finger joints). At the time of the report, JOINT SWELLING (swelling of both wrists) and ARTHRALGIA (pain in my finger joints) outcome was unknown.            The concomitant history was not reported.   The treatment history was not provided.  Patient took second dose of moderna vaccine on 31-MAR-2021 (lot number-026B21A)   This case was linked to MOD-2021-294391 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness
Clinical narrative: Left arm was a bit tight after first dose; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (Left arm was a bit tight after first dose) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015N20A) for COVID-19 vaccination.     The patient's past medical history included Broken leg (The patient  broken leg and broken ankle, since 2 years. so, she is in a wheelchair.) and Broken ankle (The patient  broken leg and broken ankle, since 2 years. so, she is in a wheelchair.). Concurrent medical conditions included Spinal fusion and Type 1 diabetes mellitus. Concomitant products included INSULIN for Type 1 diabetes mellitus, VITAMINS NOS and OXYCODONE for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE TIGHTNESS (Left arm was a bit tight after first dose). At the time of the report, MUSCLE TIGHTNESS (Left arm was a bit tight after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-294374 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Illness, Lymphadenopathy, Product dose omission issue
Clinical narrative: She hasn't taken 2nd dose yet because of side effects; She had a very bad weakness; Felt sick for couple of weeks after 1st dose; She also had swollen lymph nodes, She still has them.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (She hasn't taken 2nd dose yet because of side effects), ASTHENIA (She had a very bad weakness), ILLNESS (Felt sick for couple of weeks after 1st dose) and LYMPHADENOPATHY (She also had swollen lymph nodes, She still has them.) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was reported.  Concurrent medical conditions included Diabetes and Blood pressure high.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She hasn't taken 2nd dose yet because of side effects), ASTHENIA (She had a very bad weakness), ILLNESS (Felt sick for couple of weeks after 1st dose) and LYMPHADENOPATHY (She also had swollen lymph nodes, She still has them.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (She hasn't taken 2nd dose yet because of side effects) had resolved, ASTHENIA (She had a very bad weakness) and ILLNESS (Felt sick for couple of weeks after 1st dose) outcome was unknown and LYMPHADENOPATHY (She also had swollen lymph nodes, She still has them.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant includes diabetes and high blood pressure medications. Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, White blood cell count
Clinical narrative: Just a very sore arm for a while, lasted of couple a weeks; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (just a very sore arm for a while, lasted of couple a weeks) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced MYALGIA (just a very sore arm for a while, lasted of couple a weeks). At the time of the report, MYALGIA (just a very sore arm for a while, lasted of couple a weeks) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: high (High) High- Before vaccination.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient said that last summer went to ER because a problem with intestines and that white blood cells high (before vaccination) so was taking medication for that. Patient did not take medication to treat symptoms. No Concomitant medications were provided.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in her arm to the wrist; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her arm to the wrist) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Aug-2021, the patient experienced PAIN IN EXTREMITY (pain in her arm to the wrist). At the time of the report, PAIN IN EXTREMITY (pain in her arm to the wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-134310 (Patient Link).